Buchler GmbH
  • Products
    • Active Pharmaceutical Ingredients
    • Asymmetric Synthesis
      • Chiral Building Blocks
      • Chiral Phase Transfer Catalysts (PTCs)
      • Chiral Screening Kit
      • Enantioselective Organocatalysts
      • Racemic Resolution
    • Food Ingredients
    • Product Overview
  • Chiral Catalyst Search
  • Contact
  • About
    • Certificates
    • Company Policy
    • Former Buchler Company Managers
    • Galleries
      • Gallery current production and storage
      • Gallery Laboratory
      • Gallery Historical Production
    • History of Buchler
  • Career
Select Page

Trifluoromethylsilylation, (chloromethyl)dimethyl(trifluoromethyl)silane, substituted 1-phenylbutan-1-one, substituted (4S,6R)-4-substituted-2,2,dimethyl-6-phenyl-6-(trifluoromethyl)-1,2-oxasilinane, (9S)-(9′′S)-1,1′′-[1,3-phenylenebis(methylene)]bis[9-hydroxy-cinchonanium bromide (1:2), Cinchonine Derivative

Cyclization, Cyclization, Further Cyclizations, Trifluoromethylation

Michael Addition, nitro esters, α,β-unsatureted ketones, substituted 2-nitro-5-oxo-5-substituted-pentanoate, (9R)-Cinchonan-9-amine, Cinchonine Derivative

Michael, Michael Addition

Michael Addition, (E)-4,4,4-trifluoro-1-(4-methoxyphenyl)but-2-en-1-one, (3s,5s,7s)-adamantan-1-yl 2-((diphenylmethylene)amino)acetate, (3S,5S,7S)-adamantan-1-yl (2R,3R)-5-(4-methoxyphenyl)-3-(trifluoromethyl)-3,4-dihydro-2H-pyrrole-2-carboxylate, 1-[[3,5-bis(1,1-dimethylethyl)phenyl]methyl]-9-hydroxy-(9S)-Cinchonanium bromide, Cinchonine Derivative

Cyclization, Cyclization, Michael, Michael Addition

Aldol reaction, methyl (E)-4-(3-nitrophenyl)-2-oxobut-3-enoate, acetone, methyl (S,E)-2-hydroxy-2-(3-nitrostyryl)-4-oxopentanoate, 4-nitrobenzoic acid, (9R)-Cinchonan-9-amine, Cinchonine Derivative

Aldol, Aldol

Aza-Michael Addition, 3-methylisoxazol-5(4H)-one, 2,6-di-tert-butyl-4-(2-chlorobenzylidene)cyclohexa-2,5-dien-1-one, N-[3,5-Bis(trifluoromethyl)phenyl]-N′- [(8α,9S)-6′-methoxycinchonan-9-yl]thiourea, Quinine Derivative

Aza-Michael, Michael Addition

Bromolactonization, 4-phenylpent-4-enoic acid, N-bromosuccinimide, (S)-5-(bromomethyl)-5-phenyldihydrofuran-2(3H)-one, N-[(8α,9S)-2′-(9-Anthracenyl)-6′-methoxycinchonan-9-yl]-2,4,6-trimethoxybenzamide, Quinine Derivative

Bromination, Cyclization, Lactonization

Bromolactonization, 4-phenylpent-4-enoic acid, N-bromosuccinimide, (S)-5-(bromomethyl)-5-phenyldihydrofuran-2(3H)-one, 2,4,6-Trimethoxy-N-[(8α,9S)-6′-methoxycinchonan-9-yl]benzamide, Quinine Derivative

Bromination, Cyclization, Lactonization

Bromolactonization, 4-phenylpent-4-enoic acid, N-bromosuccinimide, (R)-5-(bromomethyl)-5-phenyldihydrofuran-2(3H)-one, 2,3,4-Trimethoxy-N-[(8α,9S)-6′-methoxycinchonan-9-yl]benzamide, Quinine Derivative

Bromination, Cyclization, Lactonization

Bromolactonization, substituted (Z)-enynes, N-bromosuccinimide, substituted bromoallenes, N-[[[(8α,9S)-6′-Methoxycinchonan-9-yl]amino]carbonyl]-4-methylbenzenesulfonamide, Quinine Derivative

Bromination, Cyclization, Lactonization

Bromolactonization, deactivated olefinic acids, N-bromosuccimide, bromolactones, N-(4-Ethoxy-2,5-dimethylphenyl)-N′-[(8α,9S)-6′-methoxycinchonan-9-yl]urea, Quinine Derivative

Bromination, Cyclization, Lactonization

« Older Entries
Next Entries »

Glossary

Impressum / Legal Notice

Code of Conduct

Hinweisgebersystem / Whistleblowing System

Allgemeine Geschäfts-bedingungen / General Terms and Conditions

Datenschutzhinweise / Data Protection Information

Contact

My Account
  • Follow
  • Follow

All Rights Reserved by Buchler GmbH